R&G PharmaStudies Co (SZSE:301333) Scaled Net Operating Assets : 0.04 (As of Mar. 2024)

R&G PharmaStudies Co Scaled Net Operating Assets Chart

R&G PharmaStudies Co Annual Data
	Trend	Dec13	Dec14	Dec15	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Scaled Net Operating Assets		Get a 7-Day Free Trial					-0.07	0.12	0.16	0.13	0.03

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.05	0.06	0.04	0.03	0.04

Competitive Comparison of R&G PharmaStudies Co's Scaled Net Operating Assets

For the Biotechnology subindustry, R&G PharmaStudies Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's Scaled Net Operating Assets falls into.

R&G PharmaStudies Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

R&G PharmaStudies Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

where

R&G PharmaStudies Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

R&G PharmaStudies Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description